Results 161 to 170 of about 40,229 (203)

Characterizing Cefepime Neurotoxicity: A Systematic Review.

open access: yesOpen Forum Infectious Diseases, 2017
Neurotoxicity due to cefepime has not been well characterized. We performed a systematic review of the literature and included 5 additional cases from our center. Of the 198 cases found, the mean age was 67 years and 87% of patients had renal dysfunction.
Rupali Jain, Shahin Hakimian
exaly   +2 more sources

Cefepime

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1994
Cefepime is a potent, broad‐spectrum, fourth‐generation cephalosporin with enhanced activity against most gram‐positive aerobic bacterial pathogens and many gram‐negative aerobic bacteria that are resistant to other cephalosporins. The drug's zwitterionic structure contributes to more rapid penetration of gram‐negative bacterial cell membranes, and its
T C, Hardin, T S, Jennings
openaire   +3 more sources

Cefepime Plasma Concentrations and Clinical Toxicity: A Retrospective Cohort Study

open access: yesClinical Microbiology and Infection, 2017
Cefepime remains an important antibiotic for severe bacterial infections, yet some meta-analyses have shown elevated mortality among patients randomized to it.
Benedikt Huttner   +2 more
exaly   +2 more sources

Cefepime Neurotoxicity: Thresholds and Risk Factors. A Retrospective Cohort Study [PDF]

open access: yesClinical Microbiology and Infection, 2020
OBJECTIVES Toxic serum cefepime trough concentrations are not well defined in the current literature. We aimed to define a more precise plasma trough concentration threshold for this antibiotic's neurological toxicity and to identify patients at risk ...
N Buetti
exaly   +3 more sources

Pharmacokinetics of cefepime: a review

Journal of Antimicrobial Chemotherapy, 1993
The pharmacokinetic profile of cefepime following single and repeated i.v. or im administration was evaluated in healthy volunteers (n = 130), volunteers with renal failure (n = 42), elderly volunteers (n = 24), and in infected patients (n = 10). Following a 30 min iv infusion of between 250 and 2000 mg, the maximum plasma concentration (Cmax) and area
Van Der Auwera, Philippe, Santella, P.J.
openaire   +3 more sources

Home - About - Disclaimer - Privacy